Komatsu M, Nishiyama R H, Bagwell C B
Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Arch Surg. 1992 Dec;127(12):1430-4. doi: 10.1001/archsurg.1992.01420120064012.
Twenty-four hyperplastic parathyroid glands from 11 patients with multiple endocrine neoplasia type I (MEN-I), and 36 hyperplastic parathyroid glands in 15 patients with sporadic primary hyperparathyroidism, ie, not associated with MEN, were analyzed for DNA by flow cytometry. Sixteen of 24 hyperplastic parathyroid glands from patients with MEN-I were DNA diploid, and eight were DNA aneuploid. Thirty-three of 36 hyperplastic parathyroid glands from patients without MEN were DNA diploid, and only three were DNA aneuploid. The mean percentage of 4c level (a measure of the G2M phase of the cell cycle) of DNA diploid hyperplastic parathyroid glands taken from patients with MEN-I was 8.1% +/- 4.5%, which is significantly higher than the 3.5% +/- 3.4% for those taken from patients without MEN. Our results show that there is a difference in nuclear DNA content between hyperplastic parathyroid glands in patients with MEN-I and those in patients without MEN.
对11例I型多发性内分泌腺瘤病(MEN-I)患者的24个增生性甲状旁腺以及15例散发性原发性甲状旁腺功能亢进患者(即不伴有MEN)的36个增生性甲状旁腺进行了流式细胞术DNA分析。MEN-I患者的24个增生性甲状旁腺中,16个为DNA二倍体,8个为DNA非整倍体。无MEN患者的36个增生性甲状旁腺中,33个为DNA二倍体,仅3个为DNA非整倍体。MEN-I患者的DNA二倍体增生性甲状旁腺的4c水平(细胞周期G2M期的一个指标)平均百分比为8.1%±4.5%,显著高于无MEN患者的3.5%±3.4%。我们的结果表明,MEN-I患者的增生性甲状旁腺与无MEN患者的增生性甲状旁腺在核DNA含量上存在差异。